Epilepsy Monitoring Device Market, By Product (Conventional Devices, Wearable Devices), By End-User, (Hospitals & Clinics, Home Care Settings, Others), By Region – Global Analysis Forecast Till 2030

The Global Epilepsy Monitoring Device Market is estimated to reach USD 755 million by 2030 with a CAGR of 4.9%.

A neurological condition known as epilepsy is characterized by abrupt and recurring sensory abnormalities, unconsciousness, or convulsions linked to aberrant electrical activity in the brain that can cause seizures and other significant problems. Early childhood epilepsy makes it challenging for parents to keep an eye on their kids. However, a medical company has developed a tool to assist parents and epileptics. This gadget can monitor seizures and guard against potentially harmful side effects.

These includes watches, anti-suffocation cushions, bracelets, and mattress gadgets. These gadgets don't treat any disorders. Yet, they are successful in bringing about mental tranquilly. Electroencephalogram (EEG) devices are used to diagnose brain abnormalities in epilepsy patients. An electroencephalogram, or EEG, is a non-invasive electrophysiological monitoring tool used to find brain electrical activity.

Market Dynamics:

Driver:

The increasing incidence of malaria, car accidents, birth-related injuries, and a stressful lifestyle can potentially increase the risk of epilepsy. In addition, lower-middle-income countries have higher rates of epilepsy in their populations due to unmet healthcare infrastructure needs and a lack of awareness. Therefore, increasing the prevalence of epilepsy could significantly drive the growth of the epilepsy monitoring device market.

Restraints:

In developing countries, high maintenance costs, complex mechanisms requiring skilled technicians, and poor reimbursement scenarios may limit the adoption of epilepsy monitoring devices. Therefore, the high cost of these devices along with maintenance and overhead costs, could pose a significant challenge for the epilepsy monitoring device market during the forecast period.

Key Players:

• Abbott Laboratories, Inc.,

• Advanced Brain Monitoring,

• Aleva Neurotherapeutics,

• BioSerenity,

• Boston Scientific Corporation,

• Cadwell Industries, Inc.,

• CGX,

• Compumedics Limited,

• Drägerwerk AG & Co. KGaA,

• Emotiv,

• Empatica, Inc.,

• Lifelines Neuro Company, LLC,

• LivAssured B.V.,

• Masimo Corporation,

• MC10, Inc.,

• Medpage, Ltd.,

• Medtronic Plc,

• Mindray Medical International Ltd.,

• Mitsar Co., Ltd., mjn

• Neuroserveis S.L.,

• Natus Medical, Inc.,

• Neurosoft,

• NeuroWave Systems, Inc.,

• Nihon Kohden Corporation,

• Rimed,

• The Magstim Co. Ltd.

Market Segmentation:

Epilepsy Monitoring Device Market, By Product

• Conventional Devices

• Wearable Devices

Epilepsy Monitoring Device Market, By End User

• Hospitals & Clinics

• Home Care Settings

• Others

Epilepsy Monitoring Device Market, By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Regional Analysis:

By region, this study provides market insights for North America, Asia Pacific, Europe, and Rest of the World. In 2021, North America accounted for a significant portion of the epilepsy devices market and is expected to retain its dominance for a fast period. Additionally, increasing number of patients undergoing neurosurgery procedures in these regions contributes to the market growth. Additionally, high purchasing power and increasing adoption of epilepsy devices are expected to drive the epilepsy monitoring device market growth.

Also, the major countries studied in the market report are the United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Scope Of the Report:

User

Tab Content